Balancing efficacy and safety in the treatment of adolescents with Hodgkin's lymphoma

Journal of Clinical Oncology

Volumn 27, Issue 36, 2009, Pages 6071-6073

  Metzger, Monika L ^a   Hudson, Melissa M ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADOLESCENT DISEASE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GONADAL DISEASE; HODGKIN DISEASE; HUMAN; LEUKEMIA; LUNG TOXICITY; PRIORITY JOURNAL; ADJUVANT THERAPY; PATHOLOGY; SURVIVAL;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HODGKIN DISEASE; HUMANS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS;

EID: 74949133657     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.3765     Document Type: Editorial

References (28)

1. Bleyer A: Adolescent and young adult (AYA) oncology: The first A. Pediatr Hematol Oncol 24:325-336, 2007
2. Burke ME, Albritton K, Marina N: Challenges in the recruitment of adolescents and young adults to cancer clinical trials. Cancer 110:2385-2393, 2007
3. Donaldson SS, Kaplan HS: Complications of treatment of Hodgkin's disease in children. Cancer Treat Rep 66:977-989, 1982
4. Mauch PM, Weinstein H, Botnick L, et al: An evaluation of long-term survival and treatment complications in children with Hodgkin's disease. Cancer 51:925-932, 1983
5. Donaldson SS, Link MP: Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol 5:742-749, 1987
6. Ekert H, Waters KD: Results of treatment of 18 children with Hodgkin disease with MOPP chemotherapy as the only treatment modality. Med Pediatr Oncol 11:322-326, 1983
7. Ekert H, Waters KD, Smith PJ, et al: Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease. J Clin Oncol 6:1845-1850, 1988
8. Ortin TT, Shostak CA, Donaldson SS: Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: The Stanford experience. Int J Radiat Oncol Biol Phys 19:873-880, 1990
9. Tucker MA, Meadows AT, Boice JD Jr, et al: Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 78:459-464, 1987
10. Schellong G: The balance between cure and late effects in childhood Hodgkin's lymphoma: The experience of the German-Austrian Study-Group since 1978-German-Austrian Pediatric Hodgkin's Disease Study Group. Ann Oncol 7:67-72, 1996 (suppl 4)
11. Hodgson DC, Hudson MM, Constine LS: Pediatric Hodgkin lymphoma: Maximizing efficacy and minimizing toxicity. Semin Radiat Oncol 17:230-242, 2007
12. Hudson MM: Achieving cure for early stage pediatric Hodgkin disease with minimal morbidity: Are we there yet? Pediatr Blood Cancer 46:122-126, 2006
13. Donaldson SS, Link MP, Weinstein HJ, et al: Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol 25:332-337, 2007
14. Tebbi CK, Mendenhall N, London WB, et al: Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: A Pediatric Oncology Group (POG) study. Pediatr Blood Cancer 46:198-202, 2006
15. Rühl U, Albrecht M, Dieckmann K, et al: Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: An interim report at 5 years of the German GPOH-HD 95 trial. Int J Radiat Oncol Biol Phys 51:1209-1218, 2001
16. Körholz D, Claviez A, Hasenclever D, et al: The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: Evolution in the tradition of the DAL/GPOH studies. Klin Padiatr 216:150-156, 2004
17. Furth C, Steffen IG, Amthauer H, et al: Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: Analysis of a prospective multicenter trial. J Clin Oncol 27:4385-4391, 2009
18. Hasenclever D, Diehl V: A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 339:1506-1514, 1998
19. Diehl V, Fuchs M: Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages? Transfus Apher Sci 37:37-41, 2007
20. Engert A, Schiller P, Josting A, et al: Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21:3601-3608, 2003
21. Canellos GP, Anderson JR, Propert KJ, et al: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327:1478-1484, 1992
22. Diehl V, Franklin J, Pfreundschuh M, et al: Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 348:2386-2395, 2003
23. Sieniawski M, Reineke T, Nogova L, et al: Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: A report of the German Hodgkin Study Group (GHSG). Blood 111:71-76, 2008
24. Eichenauer DA, Bredenfeld H, Haverkamp H, et al: Hodgkin's lymphoma in adolescents treated with adult protocols: A report from the German Hodgkin Study Group. J Clin Oncol 27:6079-6085
25. Foltz LM, Song KW, Connors JM: Hodgkin's lymphoma in adolescents. J Clin Oncol 24:2520-2526, 2006
26. Yung L, Smith P, Hancock BW, et al: Long term outcome in adolescents with Hodgkin's lymphoma: Poor results using regimens designed for adults. Leuk Lymphoma 45:1579-1585, 2004
27. Mottle AA, Fisher SG, Fisher RI, et al: Adolescents with Hodgkin lymphoma treated on adult and pediatric protocols have distinct therapeutic outcome. Blood 104:312, 2004 (abstr)
28. Armstrong GT, Liu Q, Yasui Y, et al: Late mortality among 5-year survivors of childhood cancer: A summary from the Childhood Cancer Survivor Study. J Clin Oncol 27:2328-2338, 2009